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Epstein-Barr virus, a member of the herpesvirus family, infects a large majority of the human population and is associated with
several diseases, including cancer. We have created Drosophila model systems to study the interactions between host cellular
proteins and the Epstein-Barr virus (EBV) immediate-early genes BRLF1 and BZLF1. BRLF1 and BZLF1 function as transcription
factors for viral transcription and are also potent modiﬁers of host cell activity. Here we have used our model systems to identify
host cell genes whose proteins modulate BRLF1 and BZLF1 functions. Via our GMR-R model system, we have found that
BRLF1 expression results in overproliferation of ﬂy tissue, unlike BZLF1, and does so through the interaction with known tumor
suppressor genes. Through an additional genetic screen, we have identiﬁed several Drosophila genes, with human homologs, that
may oﬀer further insights into the pathways that BRLF1 interacts with in order to promote EBV replication.
1.Introduction
Epstein-Barr virus is a human herpesvirus that infects a
majority of the human population. In addition to being the
causative agent of infectious mononucleosis, Epstein-Barr
virus (EBV) is also associated with several diﬀerent cancers.
Such malignancies include Burkitt’s lymphoma, Hodgkin’s
lymphoma, nasopharyngeal carcinoma, breast cancer, and
gastric cancer [1].
EBV can exist in a productive (lytic) phase or dormant
(latent) phase. The EBV genome encodes more than 85
genes, subsets of which are expressed during the latent phase
or during the lytic phase (which is broken down further
into immediate-early, early, and late genes). BRLF1 (R) and
BZLF1 (Z) are essential transcriptional activators expressed
during the lytic phase that activate transcription of the
EBV early genes. R and Z also have important roles in
modulating the intracellular environment. For instance, R
hasbeenshowntointeractwithandalterthefunctionsofthe
transcriptional regulators CREB-binding protein (CBP), Rb,
and MCAF1 [2–4]. The Ran-binding-protein M (RanBPM)
has also been shown to directly bind to R and act as
a coactivator of R-mediated transcription [5]. R has been
showntopromotecellcycleprogressionbyactivatingSphase
in ﬁbroblast and epithelial cell lines [6], and conversely to
promote senescence in an epithelial cell line [7]. Recently,
R has been shown to inhibit expression of IRF3 and IRF7,
leading to a decrease in the induction of interferon-β [8].
All of these ﬁndings have been accomplished via cell culture
studies.
In order to study viral protein function in a more com-
prehensive way, we have created Drosophila model systems
for both R and Z. We previously examined Z protein activity
in Drosophila a n dw e r ea b l et oi n v e s t i g a t eZ ’ sf u n c t i o na t
both the molecular and genetic level [9]. We identiﬁed the
Drosophila gene shaven as a potent modiﬁer of Z activity
in ﬂy tissue [9]. The human homolog of shaven, Pax5, also
interacted with Z in human cells and plays an important role
in EBV biology [9].
There are several cellular pathways that are important
for cell cycle regulation within Drosophila. These pathways
contain numerous tumor suppressors that, when mutated,
contribute to tissue overgrowth. These tumor suppressors
generally fall into one of three classes: hyperplastic (muta-
tions that cause increased cell proliferation with normal
tissue structure), such as those in the target of rapamycin2 The Scientiﬁc World Journal
Table 1: Candidate gene screen of tumor suppressors.
Allele Nature of allele∗ Eﬀect
14-3-3zetaP1375 P element insertion Enhancer of R
brat1,b r a tk06028 EMS, P element
insertion Enhancer of R
Cskc04256 P element insertion Enhancer of R
GMR-E2F Overexpresser Enhancer of R
InRE19 EMS Enhancer of R
Merlin4 loss of function Enhancer of R
Rab5EY10619 P element enhancer
upstream, Enhancer of R
Rab5KG05684 P element insertion Enhancer of Z
(Rab5EY10619 only)
agoEY19092 P element insertion Enhancer of Z
dlg1G0276 P element insertion Enhancer of Z
GMR-p53 Overexpresser Enhancer of Z
Suppressor of R
GMR-reaper Overexpresser Enhancer of Z
Suppressor of R
Ras85e1B EMS missense
mutation Enhancer of Z
TorDeltaP,T o r k17004 Deletion, P element
insertion
Enhancer of Z
Suppressor of R
awdj2A4 P element insertion Suppressor of R
chicoKG00336 P element insertion Suppressor of R
GMR-dacapo Overexpresser Suppressor of R
GMR-Rbf Overexpresser Suppressor of R
scribj7b3 Hypomorph Suppressor of R
hyd15 EMS Suppressor of Z
l(2)gd1EY04750 P element insertion Suppressor of Z
14-3-3epsilons−969 antimorph Suppressor of Z
∗Information about alleles from FlyBase.
EMS: ethyl methanesulfonate; hypomorph: less protein activity; antimorph:
dominant negative protein activity.
(Tor) or insulin receptor pathways, neoplastic (mutations
that cause increased cell proliferation with abnormal tissue
structure and cause invasiveness) such as those in the
discs large (dlg) or Rab5 pathways, and nonautonomous
(the overgrowth of wild-type cells due to neighboring cells
being mutant) such as those in the hyperplastic discs (hyd)
pathway [10]. Most of these tumor suppressors have human
homologs that function in the same manner as in Drosophila
cells.
Here we have made use of Drosophila’s powerful genetic
system to investigate R function and to investigate the
pathways by which R may cause aberrant cell division. Via
ourGMR-Rmodelsystem,wefoundthatRexpressioncauses
overproliferation in ﬂy tissue, as it has done in human cell
culture. Through genetic screens, we have identiﬁed several
WT
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Figure 1: BRLF1 protein expression in the GMR-R/+ eye imaginal
disc. Wild-type (a) and GMR-R/+ (b) imaginal eye discs were
stained with an anti-BRLF1 antibody. Confocal microscopy was
used to image the discs. The arrow refers to the morphogenetic fur-
row.
Drosophila genes that are important for this R-mediated
phenotype. The genes identiﬁed conﬁrm previous ﬁndings
from human cell culture and oﬀer insights into how R
interacts with host cell proteins and pathways to promote
EBV replication.
2.MaterialsandMethods
2.1.FlyCulture. Fliesweremaintainedat20◦Cinplasticvials
on a medium of cornmeal, yeast, molasses, and agar with
methyl 4-hydroxybenzoate added as a mold inhibitor. w1118
was used as the wild-type line. Fly stocks for the genetic
screens were purchased from the Bloomington stock center.
Crosses were performed at 20◦.
2.2. P-Element-Mediated Transformation. The BRLF1 cDNA
was cloned into the pGMR vector. Germline transformations
were performed using the standard P-element protocol [11].
Several GMR-R lines were isolated.
2.3. Scanning Electron Microscopy. F l i e sw e r es t o r e di n
95% ethanol until ready to be sputter-coated. Flies were
dried brieﬂy, mounted onto stubs, and sputter-coated with
gold. Sputter-coated ﬂies were imaged in a Leica scanning
electron microscope and images recorded at 2000x and 500x
magniﬁcations.
2.4. Immunostaining of Imaginal Discs. Eye-antenna imagi-
nal discs were immunostained as described [12]. The anti-R
antibody (Argene) was used at a 1:50 dilution and the anti-
phospho-histone H3 antibody (Upstate) used at a 1:1000The Scientiﬁc World Journal 3
Table 2: EP Line (second chromosome) Genetic Screen: Suppressors (S) and Enhancers (E) of the GMR-R phenotype.
Class Drosophila gene Insertion∗∗ Human homolog Function
S Beta coatomer protein Upstream COPB2 Vesicle transport from Golgi
S Defective proventriculus Within SATB1 Transcription/chromatin
organization
S Paxillin Within TGFβ1I1 Signal transduction/adaptor
S Rack1 Within GNB2L1 Signal transduction
S RanBPM Upstream RANBP9 Scaﬀolding/proapoptotic
E∗ cdc14 Within/up CDC14A Phosphatase/cell cycle/p53
E∗ Chip Upstream LDB2 LIM domain binding
E∗ Female sterile (2) ketel Upstream KPNB1 Protein import into nucleus
E∗ NAT1 Within/up EIF4G2 Repressor of translation initiation
E∗ Tre oncoprotein related Upstream TBC1D3C Rab GTPase activator
E∗ Yippee interacting protein 2 Within/up ACAA2 Acetyl Coa-acyltransferase
E 14-3-3 zeta Within YWHAZ Signal transduction/insulin pathway
E Alpha-adaptin Upstream AP2A2 Clathrin-coated vesicle transport
E Bicoid-interacting protein 3 Upstream MEPCE Transcription
E cdGAPr Within/up AC108065 GTPase activator
E CG16896 Upstream WDR67 Rab GTPase activator
E Chickadee Within/up PFN4 Cytokinesis
E Genghis khan Upstream CDC42BPA Phosphorylation/actin
polymerization
E Pendulin Within/up KPNA Importin alpha 2/nuclear import
E RhoGEF2 Within ARHGF12 Rho GEF/actin dynamics
E Shroom Within SHROOM3 Actin binding
E TBPH Upstream TARDBP Mrna binding/repressor of
transcription
∗Indicates a strong enhancer of the GMR-R phenotype.
∗∗Indicates whether the p element insertion, containing the enhancer, lies upstream, where it likely causes overexpression of the gene, or within, where it
likely interrupts the coding region. Within/up indicates that the p element lies in the 5  untranslated region of the gene.
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Figure 2: The GMR-R phenotype. SEMs of wild-type (a, b), GMR-R2 heterozygous (c, d), GMR-R2 homozygous (e, f), GMR-R3
heterozygous (g, h), and GMR-R3 homozygous (i, j) eyes are presented. The images are presented as 500x (top panels) and 2000x (bottom
panels). Arrow points to hair-like bristles.4 The Scientiﬁc World Journal
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Figure 3: Sections of GMR-R adult eyes. Adult eyes from wild-
type (a), GMR-R2/+ (b) and GMR-R3/+ (c) were embedded and
sectioned. Arrows in (a) and (b) refer to photoreceptor clusters,
arrowin(c)referstopigmentgranules.Notethatthephotoreceptor
cluster in (b) contains eight photoreceptors instead of seven.
dilution. Each primary antibody was incubated with several
(∼10) discs overnight. The secondary antibodies (donkey
anti-mouse CY3 and donkey anti-rabbit FITC (Jackson
Immunoresearch)) were used at a 1:2000 dilution, and were
incubatedwiththediscsfor2hr.Discsweremountedinanti-
fade media (Dako Cytomation). Images were obtained by
confocal microscopy and analyzed with FluoView software
and MicroSuite software.
3. Results
3.1. BRLF1 Produces a Dose-Sensitive Rough Eye Phenotype in
Drosophila. BRLF1 transgenic ﬂies were created by cloning
the BRLF1 cDNA into the Drosophila P-element vector
pGMR (Glass-mediated response) [13]. This vector allowed
for eye-speciﬁc expression of BRLF1. Expression from this
construct begins during the larval stage, with a peak during
the third larval instar and can be seen in cells posterior to the
morphogenetic furrow in eye imaginal discs (Figure 1(b)).
Several lines of GMR-R were obtained, each with a dose-
sensitive phenotype. Expression of BRLF1 in the Drosophila
WT
a p
(a)
GMR-R3
a p
(b)
Figure 4: Increased cell division in GMR-R eyes. Third instar eye
imaginal discs from wild-type (a) and GMR-R3 (b) larvae were
stained with anti-phospho-histone-H3 (Ser 10) antibody. Confocal
microscopy was used to image the discs. Arrows refer to the mor-
phogenetic furrows. Posterior is to the left of each morphogenetic
furrow.
eyeresultedinaroughadulteyephenotype(Figure 2).While
wild-type eyes had an organized pattern of ommatidia (Fig-
ures 2(a) and 2(b)), ﬂies heterozygous for GMR-R2 (GMR-
R2/+) had an unorganized ommatidial and bristle structure
(Figures 2(c) and 2(d)). Flies homozygous for GMR-R2 had
a more severe eye phenotype, including a loss of ommatidia,
and included the appearance of short hair-like bristles
(Figures 2(e) and 2(f)). The GMR-R line GMR-R3 (Figures
2(g)–2(j))displayedamoreseverephenotypethantheGMR-
R2 line (Figure 2(c)–2(f)). The number of short, hair-like
bristles was greatly increased, especially in homozygousThe Scientiﬁc World Journal 5
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Figure 5: Expression of Z counteracts the overproliferation pheno-
type within GMR-R eye discs. Third instar eye imaginal discs from
wild-type (WT), GMR-R3, GMR-Z, and GMR-R/GMR-Zl a r v a e
were stained with anti-phospho-histone-H3 (Ser 10) antibody. The
number of positively stained cells within the furrow or posterior
to the furrow was counted. Cells from approximately 12 discs were
counted for each genotype. Error bars show the standard error;
∗indicates a P value < 0.0001.
GMR-R3 eyes. GMR-R ﬂies, and especially GMR-R3 ﬂies,
had a darker red eye color than wild type (data not shown).
When adult eyes were sectioned, we found that GMR-R2/+,
with the more mild phenotype (Figure 2(d)), had disor-
ganized but recognizable ommatidia (Figure 3(b)), while
GMR-R3/+, with the more severe phenotype (Figure 2(h)),
had no recognizable ommatidial structures, but had an over-
abundance of pigment granules (Figure 3(c)).
3.2. Expression of BRLF1 Causes Overproliferation of Eye Cells.
As previous work suggested that BRLF1 expression increased
entry into the cell cycle in tissue culture cells [6], we tested
whether BRLF1 also increased entry into the cell cycle in
GMR-R discs. To identify mitotic cells in the eye discs, we
stained wild-type and homozygous GMR-R3 discs with an
anti-phospho-histone H3 (Ser 10) antibody. As histone H3
is phosphorylated on Ser 10 during mitosis, this antibody
identiﬁes mitotic cells only. In wild-type discs, mitotic cells
were seen in the morphogenetic furrow, with some mitotic
cells anterior to and posterior to the furrow (Figure 4(a)).
In GMR-R3 discs, more mitotic cells were found in the
morphogenetic furrow as well as more mitotic cells posterior
to the furrow (Figure 4(b)). The number of cells in the
furrow and that posterior to the furrow were counted in
wild-type and GMR-R3 discs. Figure 5 shows that GMR-R3
discs have an average of 1.5 times more cells in mitosis than
wild-type discs. Overproliferation was also evident in GMR-
Radulteyes.Figure 3(b)showsarepresentativeommatidium
that contained an extra photoreceptor cell. In addition,
Figure 3(c) shows an overabundance of pigment granules,
which contributed to the darker adult eye color in these ﬂies.
3.3. Genetic Interaction between GMR-R and GMR-Z. We
have previously analyzed the expression of the EBV BZLF1
gene in Drosophila [9]. The GMR-Z/+ phenotype was
diﬀerent than that of GMR-R and included a rough eye
phenotype and diminished pigment. Homozygosity for
GMR-Z (referred to as “strong Z”) led to a loss of ommatidia
(leavingasmootheye)andacompletelossofpigment.Inour
studies we found that strong Z inhibited the cell cycle and
prevented the diﬀerentiation of cone cells in homozygous
GMR-Ze y e s[ 9].
Although the GMR-R and GMR-Z phenotypes seem to
be antagonistic to each other (as R increases entry into
the cell cycle and Z decreases entry into the cell cycle),
during the normal EBV infection process, the two proteins
R and Z are expressed at the same time and in fact work
together to promote EBV gene expression [14]. Therefore
we crossed GMR-R3 and GMR-Z ﬂies and examined their
progeny (Figure 6). We also counted the number of mitotic
cells in GMR-R3/weak GMR-Z larval eye discs. We found
that while Z alone did not signiﬁcantly alter the number of
mitotic cells in eye discs, expression of Z did reverse GMR-
R3 overproliferation, such that the number of mitotic cells
in GMR-R3/weak GMR-Z eye discs was half that of those in
GMR-R3 alone (resulting in a lower number than wild type)
(Figure 5). This reversal of the GMR-R3 phenotype can be
seen in Figure 6(h), as the number of short hair-like bristles
was also decreased. The eye color of the trans-heterozygotes
was very similar to the GMR-Z/+ eye color (orange),
suggesting that the pigment cells had not over-proliferated as
in GMR-R3 eyes. However, Figures 6(g) and 6(h) shows that
the GMR-R3/weak GMR-Z trans-heterozygous ﬂies had a
complete loss of ommatidia, although the bristles remained.
This suggests that while Z counteracted the overproliferation
phenotype of R, the presence of R and Z together elicited
a signiﬁcant cellular response causing the eventual loss of
ommatidial cells.
3.4. GMR-R and GMR-Z Genetically Interact with Growth
Regulator Mutants. Both R and Z impact cell division,
e i t h e rp o s i t i v e l yo rn e g a t i v e l y .H o w e v e r ,GMR-R and GMR-
Z genetically interact to produce a more severe phenotype
thaneitheralone,suggestingthattheyparticipateindiﬀerent
pathways. To elucidate these pathways, we performed a
genetic screen with candidate genes—known genes involved
in growth regulation. We crossed both GMR-R3 and GMR-
Z to ﬂies mutant for or overexpressing genes involved in
cell cycle, signal transduction, and apoptosis. In most cases,
more than one allele for each gene was tested. Enhancers
of the GMR-R phenotype were those that increased the
roughness/disorganization/pigmentation of the eye tissue,
and/or increased the number of short hair-like bristles
(e.g., see Figures 7(i) and 7(j)). Suppressors of the GMR-
R phenotype were those that restored the eye to a more
wild-type organization of ommatidia/pigmentation; this was
typically accompanied by a reduction in the number of short
hair-like bristles (e.g., see Figures 7(e), 7(f), 7(m), and 7(n)).
Enhancers of the GMR-Z phenotype were those that led to
a loss of ommatidia and pigmentation, while suppressors of
the GMR-Z phenotype were those that restored wild-type
ommatidial organization and pigmentation. Of the 51 genes
tested, 15 modiﬁed the GMR-R3 phenotype and 10 modiﬁed
theGMR-Zphenotype(Table 1).Ofthese,therewere4genes
that modiﬁed both the GMR-R and GMR-Z phenotypes:
Rab5, p53, reaper,a n dTor.6 The Scientiﬁc World Journal
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Figure 6: BZLF1 expression alters the GMR-R phenotype. A cross was performed between GMR-R and GMR-Z ﬂies. SEMs were taken at
500x (top panels) and 2000x (bottom panels). Wild-type (a, b), GMR-R3/+ (c, d), GMR-Z/+ (e, f), and GMR-R/GMR-Z (g, h) adult eyes are
presented.
Table 1 shows that ﬂy lines that over-expressed the
wild-type tumor suppressors Rbf (homolog of Rb), dacapo
(homolog of p21), and p53 suppressed the R overpro-
liferation phenotype, while the overexpression of the cell
cycle promoter E2F o ral o s so fat u m o rs u p p r e s s o r( brat,
Csk, Merlin) enhanced the R overproliferation phenotype.
Conversely, ﬂy lines that had a loss of a tumor suppressor
(hyd, l(2)gd1) suppressed the Z phenotype, while the loss of
cell cycle promoters (Ras85) enhanced the Z phenotype.
Interestingly, four ﬂy gene mutants aﬀected both the
GMR-R and GMR-Z phenotypes. The GMR-R overprolifera-
tion phenotype was suppressed by over-expression of the cell
cycleinhibitorp53,aswellasbytheproapoptoticgenereaper;
the GMR-Z phenotype was enhanced by over-expression of
both p53 and reaper. Decreased levels of Tor suppressed the
GMR-R phenotype, while the same mutants enhanced the
GMR-Z phenotype. Furthermore, misexpression of Rab5,a
GTPase that promotes endocytic vesicle fusion and helps
terminate signaling pathways, enhanced both the GMR-R
and GMR-Z phenotypes.
To further deﬁne R’s biological role in cells, we per-
formed a more objective genetic screen by crossing GMR-
R3 to the second chromosome EPgy2 misexpression line
collection [15]( http://ﬂystocks.bio.indiana.edu/Browse/in/
misexpression-top.php). Each of these approximately 1000
lines tested contained a P element inserted either upstream
of or within the coding region of a speciﬁc gene, causing
that gene to either be overexpressed (if upstream) or mutant
(if within). Lines that caused either enhancement or sup-
pression of the GMR-R phenotype were crossed to a control
line (GMR alone). Enhancers or suppressors that were
speciﬁc to the GMR-R phenotype are presented in Table 2.
Forty-nine genes were identiﬁed; only genes with human
homologs and deﬁned protein functions have been listed (22
of the 49). While some genes identiﬁed are involved in cell
cycle regulation (cdc14), others are involved in signal trans-
duction (Paxillin, Rack1, 14-3-3 zeta, cdGAPr) regulating
thecytoskeleton(RhoGEF2,genghiskhan,Shroom,chickadee)
and vesicle transport (beta coatomer protein, alpha-adaptin)
and speciﬁcally Rab GTPase activators (CG16896, TRE
oncoprotein related). Others are transcriptional regulators
(defective proventriculus, bicoid interacting protein 3, TBPH)
or are involved in protein import into the nucleus (Female
sterile (2) ketel, PENdulin). Interestingly, the overexpression
of RanBPM, a scaﬀolding protein involved in many signal
transduction pathways [16], suppressed the R phenotype;
it has been previously reported that RanBPM physically
interactswithRandpromotesthetransactivationabilityofR
in human B cells [5]. Also, while not listed in Table 2, the EP
line screen identiﬁed brat as a potent modiﬁer of the GMR-R
phenotype, conﬁrming our results in Table 1. brat does not
have a human homolog, but functions as a tumor suppressor
in Drosophila brain tissue [17].
4. Discussion
We have created a model system to investigate the cellular
consequences of R expression. We found that R is expressed
in the nuclei of eye cells while under the control of the GMR
promoter element and that R expression causes more cells to
enter the cell cycle. This overproliferation is evident from the
GMR-R mutant eye phenotype—the ommatidia and bristles
become unorganized, an overabundance of pigment leads to
a dark red eye color, and short, ﬁne bristles appear. TheseThe Scientiﬁc World Journal 7
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Figure 7: The GMR-R phenotype is suppressed by Drosophila Rb and p21 and enhanced by E2F. Crosses were performed between GMR-R3
and GMR-Rbf, GMR-E2F,a n dGMR-dacapo. SEMs, at 500x and 2000x, are shown for GMR-R3/+ (a, b), GMR-Rbf/+ (c, d), GMR-R3/GMR-
Rbf (e, f), GMR-E2F/+ (g, h), GMR-R3/GMR-E2F (i, j), GMR-dacapo/+ (k, l), and GMR-R3/GMR-dacapo (m, n).
R-mediated eﬀects are dose sensitive—the more R expressed,
themoreseverethephenotype.ThecoexpressionofZcurbed
the overproliferation phenotype in GMR-R eyes: fewer cells
underwent mitosis in larval eye discs, and there was less
pigment and fewer hair-like bristles in adult eyes. However
the combination of R and Z did not produce a wild-type eye,
as a diﬀerent mutant phenotype took the place of both the
GMR-R and GMR-Z phenotypes in GMR-R/GMR-Ze y e s .
In order to determine which cellular genes were medi-
ating the GMR-R and GMR-Z phenotypes, we performed a
candidate gene screen with both the GMR-R and GMR-Z
ﬂies, as well as an additional EP line screen with the GMR-
R ﬂies (Tables 1 and 2). Via the tumor suppressor candidate
gene screen, we were able to determine that R’s ability to
promote the cell cycle is sensitive to the activities of a
varietyofcellcycleregulators,especiallythosefallingintothe8 The Scientiﬁc World Journal
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Figure 8: Model of R’s eﬀect upon S phase entry. Unless given a
signal, cells will have Rb bound to E2F to inhibit E2F activity. R
protein binds to Rb, displacing it from E2F, in which case E2F will
promote S phase entry. Overexpression of E2F enhances this eﬀect.
OverexpressionofRballows for renewed E2Finhibition.p53or p21
overexpression inhibits cell cycle progression after it is initiated by
active E2F.
Drosophila hyperplastic growth category. Our work conﬁrms
previous work showing that R interacts with Rb and E2F to
promote entry into the cell cycle [3, 6] (for our model, see
Figure 8), but also indicates that R activity is inﬂuenced by a
number of signaling pathways, including the insulin receptor
pathway and the Tor pathway. It is interesting to note that
from this screen we found an equal number of enhancers for
both R and Z (7 each), but more suppressors for R than for
Z (8 for R versus 3 for Z). Therefore it appears to be “easier”
to suppress R activity than to suppress Z activity.
From the EP line screen with GMR-R, we identiﬁed 5
suppressors and 17 enhancers of R activity. It is interesting
to note that many of these modiﬁers code for proteins that
are involved in protein/vesicle traﬃcking. Speciﬁcally, we
identiﬁed two genes involved with protein transport into
the nucleus: Female sterile (2) ketel and Pendulin.I ta p p e a r s
that the likely overexpression of Female sterile (2) ketel and
Pendulin leads to the enhancement of R activity, perhaps
due to an increase of R protein import into the nucleus.
Similar to our ﬁnding that Rab5 was a modiﬁer of both R
and Z activity in our candidate gene screen, we identiﬁed
other genes involved in vesicle traﬃcking, as well as Rab
GTPase activators, as modiﬁers of R activity in this screen.
Namely, the likely overexpression of tre oncoprotein related
and CG16896, both Rab GTPase activators, enhanced the
GMR-R phenotype, just as overexpression of Rab5 (Table 1)
enhanced the GMR-R phenotype. Rab proteins are involved
in vesicle traﬃcking, and Rab5 is speciﬁcally involved in
endocytosis [18].
Another class of genes that modify R activity are
signaltransductionmediators:Paxillin,Rack1,RanBPM,and
14-3-3zeta. The fact that we found so many adaptors, which
are involved in a variety of signal transduction pathways,
to modulate R activity, indicates that the R protein exerts
its eﬀects via manipulation of several diﬀerent signaling
pathways.
We are very interested in the four genes that we identiﬁed
in our candidate gene screen that modify both the GMR-R
and GMR-Z phenotypes: reaper, p53, Rab5,a n dTor.A sb o t h
R and Z are present together in lytically replicating EBV-
positive cells and they both contribute to transactivation of
EBV early genes as well as to manipulation of their cellular
environments, we are interested in cellular pathways that
are common to both. We are especially interested in the
mammalian mTOR pathway, which controls cell growth
and protein translation [19] and how it will aﬀect R and
Z functioning during EBV lytic replication, as well as the
mammalian Rab5 protein, and how vesicle traﬃcking may
aﬀect or be aﬀected by EBV lytic replication.
Overall, we have established a model of R activity that
mimics how the protein functions in human cells and have
identiﬁed several cellular mediators of R activity that will be
interesting foci for future study.
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